Jaeyong Ahn
Tracked across 4 events · 28 articles · First seen May 25, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Jaeyong Ahn>>>, President and CEO of Altor BioScience>>>, expressed honor in participating in Colombia's national initiative and committed to contributing to future pandemic preparedness.
May 25, 2026 · 9 articles
Business
Impact: Jaeyong Ahn>>>, CEO of Altor BioScience>>>, expressed commitment to global public health through the development of the rotavirus vaccine.
Jun 09, 2026 · 6 articles
Regulatory
Impact: Jaeyong Ahn, CEO of Altor BioScience, expressed the company's commitment to investing in pipeline development and manufacturing infrastructure following the Canada — Canada Growth Fund selection.
May 29, 2026 · 6 articles
Tech
Altor BioScience submitted a Clinical Trial Application to the South Africa — South African Health Products Regulatory Authority (SAHPRA) for a global pediatric Phase 1b clinical trial of RSM01, a respiratory syncytial virus (RSV) preventive…
Impact: As CEO, Jaeyong Ahn announced the milestone and expressed confidence in the company's strategy, supporting positive sentiment.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Jaeyong Ahn live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard